Electromedical Technologies, Inc. EMED

FY2023 · ended Dec 31, 2023 · Revenue $1.35M, +17.3% YoY · Filed May 1, 2024

Electromedical Technologies, Inc. (EMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2023, which ended Dec 31, 2023, it reported revenue of $1.3 million and a net loss of $2.6 million. Free cash flow was -$1.6 million. As of Sep 30, 2024 it held $34,809 in cash and investments and $131,562 in total debt.

Revenue (TTM)
$922,010
-35.1% vs year-ago TTM
Net income (TTM)
$-1.68M
+46.3% vs year-ago TTM
Operating cash flow (TTM)
$-131,211
+90.6% vs year-ago TTM
Free cash flow (TTM)
$-131,211
EPS
$0.00
+100.0% vs prior year
Dividend per share
None
Shares outstanding
507.29M
+4.3% vs prior year
Net cash
$-96,753
as of Sep 30, 2024
Operating margin
-109.6%
FY 2024

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
EMED (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Scottsdale, AZ
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1715819

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
$1.3M
$1.1M
$907,362
$737,958
Operating income
-$2.1M
-$1.6M
-$3.8M
-$3.2M
Net income
-$2.6M
-$3.5M
-$8.5M
-$3.9M
Diluted EPS
$0.00
-$0.03
-$0.24
—
Operating cash flow
-$1.4M
-$773,337
-$1.2M
-$1.3M
Free cash flow
-$1.6M
—
—
—
Total assets
$748,383
$1.4M
$1.4M
$1.4M
Total liabilities
$3.6M
$3.6M
$2.1M
$2.7M
Stockholders' equity
-$2.9M
-$2.2M
-$722,503
-$1.3M
Cash and investments
$87,704
$368,425
$383,170
$264,913
Total debt
$459,890
$671,525
$702,780
$732,266

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
10-K/A Amended annual report Oct 16, 2024 Dec 31, 2023
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K/A Amended current report
Bylaw or fiscal year change
Aug 9, 2024 Jul 18, 2024
8-K Current report
Bylaw or fiscal year change
Jul 24, 2024 Jul 18, 2024
10-Q Quarterly report Jun 14, 2024 Mar 31, 2024

Source: SEC EDGAR filings. This is company-reported data, not investment advice.